Disc Medicine Inc [IRON] is -25.28% lower this YTD. Is it still time to buy?

Disc Medicine Inc [NASDAQ: IRON] plunged by -$0.67 during the normal trading session on while it closed the day at $47.37.

Disc Medicine Inc stock has also loss -1.50% of its value over the past 7 days. However, IRON stock has declined by -13.31% in the 3 months of the year. Over the past six months meanwhile, it has lost -20.45% and lost -25.28% year-on date.

The market cap for IRON stock reached $1.64 billion, with 34.58 million shares outstanding and 21.07 million shares in the current float. Compared to the average trading volume of 432.45K shares, IRON reached a trading volume of 132011 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Disc Medicine Inc [IRON]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IRON shares is $99.20 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IRON stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

TD Cowen have made an estimate for Disc Medicine Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on February 27, 2025. The new note on the price target was released on November 05, 2024, representing the official price target for Disc Medicine Inc stock. Previously, the target price had yet another raise from $66 to $110, while Raymond James kept a Strong Buy rating on IRON stock.

The Average True Range (ATR) for Disc Medicine Inc is set at 2.66 The Price to Book ratio for the last quarter was 2.48, with the Price to Cash per share for the same quarter was set at 20.06.

IRON stock trade performance evaluation

Disc Medicine Inc [IRON] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.50. With this latest performance, IRON shares gained by 2.60% in over the last four-week period, additionally sinking by -20.45% over the last 6 months – not to mention a rise of 51.54% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for IRON stock in for the last two-week period is set at 51.52, with the RSI for the last a single of trading hit 51.05, and the three-weeks RSI is set at 50.41 for Disc Medicine Inc [IRON]. The present Moving Average for the last 50 days of trading for this stock 46.55, while it was recorded at 48.81 for the last single week of trading, and 52.83 for the last 200 days.

Disc Medicine Inc [IRON]: An insightful look at the core fundamentals

Disc Medicine Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 37.65 and a Current Ratio set at 37.65.

Earnings per share (EPS) analysis for Disc Medicine Inc [IRON] stock

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for IRON. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Disc Medicine Inc go to 0.16%.

Disc Medicine Inc [IRON]: Institutional Ownership

There are presently around $98.91%, or 110.62%% of IRON stock, in the hands of institutional investors. The top three institutional holders of IRON stocks are: PARADIGM BIOCAPITAL ADVISORS LP with ownership of 2.7 million shares, which is approximately 10.5451%. ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, holding 2.51 million shares of the stock with an approximate value of $$113.1 million in IRON stocks shares; and ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, currently with $$80.93 million in IRON stock with ownership which is approximately 7.0012%.

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.